Back

Outcomes following surgical tricuspid valve intervention

28 August 2026 (09:09 - 09:27)
Organised by: Logo
Congress Presentation Part of: Tricuspid regurgitation: medical treatment, intervention, or surgery? Tricuspid Valve Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor David Messika Zeitoun

University of Ottawa Heart Institute, Ottawa (Canada)

4 More presentations in this session

Presentation thumbnail
Transcatheter options for treating tricuspid regurgitation
Doctor D. Kalbacher (Hamburg, DE)
Slides Video
Presentation thumbnail
Surgical options for treating tricuspid regurgitation
Doctor L. Torracca (Rozzano, IT)
Video
Presentation thumbnail
Outcomes following transcatheter tricuspid valve intervention
Professor N. Karam (Beirut, LB)
Slides Video
Presentation thumbnail
Tricuspid regurgitation: medical treatment, intervention, or surgery? - discussion
Video

Access the full session

Session thumbnail
Tricuspid regurgitation: medical treatment, intervention, or surgery?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 09:09 CET
You may be interested in
thumbnail
Congress Session
Interventional management of tricuspid regurgitation: the new frontier
27 August 2022
thumbnail
Congress Presentation
Risk scores: can they determine who should and should not undergo transcatheter interventions?
11 December 2025
thumbnail
Congress Presentation
Long-term benefit of isolated surgical tricuspid valve repair and replacement in patients with severe functional tricuspid regurgitation: Impact of the TRI-SCORE
30 August 2024
thumbnail
Congress Presentation
Clinical outcomes according to clinical and surgical risk scores for tricuspid regurgitation
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources